We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NANOBIOTIX Announced Positive Phase I Results of NBTXR3

News   Jun 04, 2013

 
NANOBIOTIX Announced Positive Phase I Results of NBTXR3
 
 
 

RELATED ARTICLES

Fast-acting Psychedelic Eases Depression and Anxiety

News

Researchers have discovered that use of the synthetic psychedelic, 5-methocy-N,-N-dimethyltryptamine, appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

READ MORE

Study Ties Common Heartburn Medications to Kidney Disease

News

Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.

READ MORE

Gene Medication to Treat Spinal Cord Injury

News

After several months of gene medication treatment, rodents were able to use previously paralyzed limbs, a study has found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE